Related Experiment Video

Updated: May 23, 2025

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA
09:36

RNA Pull-down Procedure to Identify RNA Targets of a Long Non-coding RNA

Published on: April 10, 2018

25.2K

[Long non-coding RNAs, new therapeutic targets for the treatment of non-small cell lung cancers?]

R Lopes Goncalves1, M Gauthier-Isola1, G Vassaux1

  • 1Inserm U1323, CNRS UMR7275, IPMC, université Côte d'Azur, Valbonne, France.

Revue Des Maladies Respiratoires
|March 11, 2025
PubMed

Insights

Long non-coding RNAs are key regulators of gene expression frequently altered in aggressive cancers. Understanding their role in non-small cell lung cancer and hypoxia can reveal new therapeutic targets.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Non-small cell lung cancer (NSCLC) is characterized by high recurrence rates and aggressiveness.
  • Identifying molecular mechanisms driving NSCLC is crucial for improved patient management.
  • Hypoxia is an important environmental factor influencing cancer development and treatment resistance.

Purpose of the Study:

  • To provide an update on long non-coding RNAs (lncRNAs) as regulators of gene expression.
  • To highlight the deregulation of lncRNAs in cancer, particularly in response to hypoxia.
  • To explore the potential of lncRNAs as biomarkers and therapeutic targets for NSCLC.

Main Methods:

  • Literature review of emerging research on lncRNAs.
  • Analysis of lncRNA deregulation in cancer.
  • Focus on the role of lncRNAs in hypoxia-related cancer progression.

Main Results:

  • lncRNAs are frequently deregulated in various cancers.
  • lncRNAs play significant roles in gene expression regulation.
  • Hypoxia induces changes in lncRNA expression, impacting cancer aggressiveness and treatment resistance.

Conclusions:

  • lncRNAs represent a promising area for discovering novel biomarkers and therapeutic strategies for NSCLC.
  • Further research into lncRNA function in hypoxic tumors is warranted.
  • Targeting lncRNAs may offer new avenues for managing aggressive lung cancers.
Keywords:
ARNlncCRISPRCarcinomes bronchopulmonaires non à petites cellulesHypoxiaHypoxieLncRNANon-small cell bronchopulmonary carcinomas

More Related Videos

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

8.8K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

997

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
5.5K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K